Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.78%
Insider Ownership
2.02%
Institutional Own.
13.42%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Ebopiprant (OBE022) Details Preterm labor | Phase 2b Update | |
YSELTY® (linzagolix) Details Benign tumor | Failed Discontinued | |
YSELTY® (linzagolix) Details Inflammatory disease, Endometriosis | Failed Discontinued |